Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459349
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-11
Brief Title:
Effects of Sensory Stimulation Versus Sensorimotor Therapy on Spasticity Motor Function and Daily Activities in Stroke
Sponsor:
Riphah International University
Organization:
Riphah International University
Study Overview
Official Title:
Effects of Exteroceptive and Proprioceptive Sensory Stimulation Versus Sensorimotor Therapy on Spasticity Motor Function and Activities of Daily Living in Patients With Stroke
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare effects of exteroceptive and proprioceptive sensory stimulation versus sensorimotor therapy on spasticity motor function and activities of daily living in patients with stroke
Detailed Description:
It will be a randomized clinical trial in which total 42 stroke patients will be recruited through non probability convenience sampling techniques Data will be collected from Gujranwala Medical College Teaching Hospital and Riphah Rehabilitation Center Lahore The patients who are fulfilling the inclusion criteria will be randomly assigned to either group A n21 which will receive intervention exteroceptive and proprioceptive sensory stimulation or to group B n21 which will receive sensorimotor therapy for 50 minutes per session 03 times a week for 06 weeks Baseline treatment will be given to both groups Conventional therapy will be given for 20 minutes per session 03 times a week for 06 weeks Data collection tools will be Fugl-Meyer Assessment Modified Barthel Index and Modified Ashworth Scale
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None